Prescription Drug Information: Clonazepam (Page 5 of 5)

PRINCIPAL DISPLAY PANEL

DRUG: Clonazepam

GENERIC: clonazepam

DOSAGE: TABLET

ADMINSTRATION: ORAL

NDC: 70518-2467-0

NDC: 70518-2467-1

NDC: 70518-2467-2

COLOR: yellow

SHAPE: ROUND

SCORE: Two even pieces

SIZE: 8 mm

IMPRINT: 2530;V

PACKAGING: 30 in 1 BLISTER PACK

OUTER PACKAGING: 100 in 1 BOX

INNER PACKAGING: 1 in 1 POUCH

ACTIVE INGREDIENT(S):

  • CLONAZEPAM 0.5mg in 1

INACTIVE INGREDIENT(S):

  • D&C YELLOW NO. 10
  • MAGNESIUM STEARATE
  • MICROCRYSTALLINE CELLULOSE
  • CROSCARMELLOSE SODIUM
  • LACTOSE MONOHYDRATE
  • SILICON DIOXIDE
Remedy_Label
(click image for full-size original)
MM2
(click image for full-size original)
MM3
(click image for full-size original)
CLONAZEPAM clonazepam tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:70518-2467(NDC:43547-406)
Route of Administration ORAL DEA Schedule CIV
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
CLONAZEPAM (CLONAZEPAM) CLONAZEPAM 0.5 mg
Inactive Ingredients
Ingredient Name Strength
SILICON DIOXIDE
CROSCARMELLOSE SODIUM
LACTOSE MONOHYDRATE
MAGNESIUM STEARATE
MICROCRYSTALLINE CELLULOSE
D&C YELLOW NO. 10
Product Characteristics
Color yellow (light yellow) Score 2 pieces
Shape ROUND Size 8mm
Flavor Imprint Code 2530;V
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:70518-2467-0 30 TABLET in 1 BLISTER PACK None
2 NDC:70518-2467-1 100 POUCH in 1 BOX contains a POUCH (70518-2467-2)
2 NDC:70518-2467-2 1 TABLET in 1 POUCH This package is contained within the BOX (70518-2467-1)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA077856 12/05/2019
Labeler — REMEDYREPACK INC. (829572556)

Revised: 01/2020 REMEDYREPACK INC.

Page 5 of 5 1 2 3 4 5

RxDrugLabels.com provides trustworthy package insert and label information about marketed prescription drugs as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by RxDrugLabels.com. Every individual prescription drug label and package insert entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.

Medication Sections

Medication Information by RSS

As a leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. RxDrugLabels.com provides the full prescription-only subset of the FDA's repository. Medication information provided here is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2020. All Rights Reserved.